Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01)

NCT06371482 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

SCLC, Limited Stage

Interventions

DRUG: Durvalumab
DRUG: Chemotherapy drug of EP regimen
RADIATION: radiotherapy

Sponsor

Hebei Medical University Fourth Hospital